Total Valuation
Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs has a market cap or net worth of ₩67.53B. The enterprise value is -₩151.80B.
Market Cap₩67.53B
Enterprise Value-₩151.80B
Share Statistics
Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs has 35,173,836 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding35,173,836
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -0.59%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-0.59%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.15
Inventory Turnover2.51
Valuation Ratios
The current PE Ratio of Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs is ―. Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs’s PEG ratio is 10.27.
PE Ratio―
PS Ratio2.83
PB Ratio0.49
Price to FCF17.83
Price to Operating Cash Flow11.28
PEG Ratio10.27
Income Statement
In the last 12 months, Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs had revenue of 112.46B and earned -347.58M in profits. Earnings per share was -9.90.
Revenue112.46B
Gross Profit53.63B
Operating Income-4.23B
Pretax Income-143.86M
Net Income-347.58M
EBITDA23.40B
Earnings Per Share (EPS)-9.90
Cash Flow
In the last 12 months, operating cash flow was -18.65B and capital expenditures -1.23B, giving a free cash flow of -19.88B billion.
Operating Cash Flow-18.65B
Free Cash Flow-19.88B
Free Cash Flow per Share-565.26
Dividends & Yields
Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs pays an annual dividend of ₩871, resulting in a dividend yield of 7.05%
Dividend Per Share₩871
Dividend Yield7.05%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.11
52-Week Price Change-51.08%
50-Day Moving Average2.26K
200-Day Moving Average2.84K
Relative Strength Index (RSI)35.03
Average Volume (3m)113.06K
Important Dates
Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs upcoming earnings date is Nov 12, 2026, TBA (Confirmed).
Last Earnings DateAug 18, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs as a current ratio of 12.38, with Debt / Equity ratio of 10.15%
Current Ratio12.38
Quick Ratio11.80
Debt to Market Cap0.05
Net Debt to EBITDA-11.80
Interest Coverage Ratio-1.22
Taxes
In the past 12 months, Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs has paid 936.00M in taxes.
Income Tax936.00M
Effective Tax Rate-6.51
Enterprise Valuation
Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs EV to EBITDA ratio is 1.79, with an EV/FCF ratio of 2.35.
EV to Sales0.37
EV to EBITDA1.79
EV to Free Cash Flow2.35
EV to Operating Cash Flow2.11
Balance Sheet
Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs has ₩409.26B in cash and marketable securities with ₩59.20B in debt, giving a net cash position of ₩350.06B billion.
Cash & Marketable Securities₩409.26B
Total Debt₩59.20B
Net Cash₩350.06B
Net Cash Per Share₩9.95K
Tangible Book Value Per Share₩18.56K
Margins
Gross margin is 47.69%, with operating margin of -3.76%, and net profit margin of -0.31%.
Gross Margin47.69%
Operating Margin-3.76%
Pretax Margin-0.13%
Net Profit Margin-0.31%
EBITDA Margin20.81%
EBIT Margin2.96%
Analyst Forecast
The average price target for Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-68.30%
EPS Growth Forecast-415.92%